1. Home
  2. MGLD vs LVTX Comparison

MGLD vs LVTX Comparison

Compare MGLD & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGLD
  • LVTX
  • Stock Information
  • Founded
  • MGLD 1996
  • LVTX 2016
  • Country
  • MGLD United States
  • LVTX Netherlands
  • Employees
  • MGLD N/A
  • LVTX N/A
  • Industry
  • MGLD Finance/Investors Services
  • LVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MGLD Finance
  • LVTX Health Care
  • Exchange
  • MGLD Nasdaq
  • LVTX Nasdaq
  • Market Cap
  • MGLD 44.8M
  • LVTX 41.3M
  • IPO Year
  • MGLD N/A
  • LVTX 2021
  • Fundamental
  • Price
  • MGLD $1.07
  • LVTX $1.54
  • Analyst Decision
  • MGLD
  • LVTX Hold
  • Analyst Count
  • MGLD 0
  • LVTX 4
  • Target Price
  • MGLD N/A
  • LVTX $1.58
  • AVG Volume (30 Days)
  • MGLD 15.1K
  • LVTX 104.7K
  • Earning Date
  • MGLD 11-07-2025
  • LVTX 08-13-2025
  • Dividend Yield
  • MGLD N/A
  • LVTX N/A
  • EPS Growth
  • MGLD N/A
  • LVTX N/A
  • EPS
  • MGLD N/A
  • LVTX N/A
  • Revenue
  • MGLD $31,205,000.00
  • LVTX $4,990,000.00
  • Revenue This Year
  • MGLD N/A
  • LVTX N/A
  • Revenue Next Year
  • MGLD N/A
  • LVTX N/A
  • P/E Ratio
  • MGLD N/A
  • LVTX N/A
  • Revenue Growth
  • MGLD N/A
  • LVTX N/A
  • 52 Week Low
  • MGLD $0.64
  • LVTX $0.85
  • 52 Week High
  • MGLD $2.10
  • LVTX $2.09
  • Technical
  • Relative Strength Index (RSI)
  • MGLD 59.78
  • LVTX 52.16
  • Support Level
  • MGLD $1.01
  • LVTX $1.53
  • Resistance Level
  • MGLD $1.15
  • LVTX $1.58
  • Average True Range (ATR)
  • MGLD 0.08
  • LVTX 0.03
  • MACD
  • MGLD 0.01
  • LVTX -0.01
  • Stochastic Oscillator
  • MGLD 75.00
  • LVTX 41.67

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.

About LVTX LAVA Therapeutics N.V.

LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.

Share on Social Networks: